Written by : Dr. Aishwarya Sarthe
March 6, 2024
The investment aims to fuel the expansion of Cardiotrack's solutions to more health and life insurance providers.
Bengaluru-based healthcare screening technology provider Cardiotrack has secured $2 million in Pre-Series A funding, led by angel investor Girish Narasimhan and a group of investors.
This infusion of capital is expected to boost Cardiotrack's healthcare screening solutions to a wider range of health and life insurance providers.
Established in 2014, by Avin Agarwal and Ashim Roy, Cardiotrack offers healthcare screenings and services to life and health insurance companies. It also offers telemedicine kits, data analytics tools, and unique screening technologies. By empowering insurance providers and consumers alike, Cardiotrack aims to make healthcare screening more accessible, efficient, and personalized globally.
Sharing insights, Avin Agarwal, founder & CEO, Cardiotrack, said, "We are thrilled to have secured this investment as we continue to innovate and expand our reach in our mission to drive positive change in the healthcare industry."
Agarwal further emphasized Cardiotrack's focus on revolutionizing healthcare screening and enhancing the overall healthcare experience for consumers and providers alike.
The infusion of capital comes as Cardiotrack aims to broaden its reach and enhance its offerings within the health and life insurance sectors. With a focus on leveraging data-centric healthcare screening technology, the company intends to extend its solutions to a wider network of health and life insurance providers.
Cardiotrack distinguishes itself through its innovative technology, which includes at-home pathology and radiology screening services conducted in over 300 locations across India.
One key feature is its ability to conduct an equivalent of a treadmill test in the comfort of one's home using video-based recorded medical examinations. These advancements provide added convenience for consumers while enabling health and life insurance providers to deliver rapid, thorough, and tailored services.
Sharing thoughts, Girish Narasimhan, the lead investor in the funding round and a member of the board at Cardiotrack, said, "Avin and the team are deeply committed to their mission to revolutionize healthcare screening. We strongly believe the venture will rightfully cement its place among startups reshaping the healthcare future."
Funding in healthtech startups has been witnessing an upward trend lately. For example, Neodocs, a healthtech startup founded in 2020, recently received funding to accelerate its expansion plans and scale up its innovative healthcare solutions.
The recent infusion of funds sought to support Neodocs in scaling its existing offerings and expanding into international markets, including Europe, Australia, the Middle East, the Philippines, and the Americas.
Likewise, Aarogya Tech, a US-based healthtech startup operating out of Bengaluru, secured seed funding to further its mission of revolutionizing the healthcare landscape.
The startup aims to shift the center of care from hospitals to homes through its accessible and intelligent health companion, driving innovation in the healthcare industry.